These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2787338)

  • 1. Effectiveness of cyclosporine treatment in severe psoriasis: a clinical and immunologic study.
    Finzi AF; Mozzanica N; Cattaneo A; Chiappino G; Pigatto PD
    J Am Acad Dermatol; 1989 Jul; 21(1):91-7. PubMed ID: 2787338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional cyclosporine in the treatment of psoriasis. A clinical, immunologic, and pharmacokinetic study.
    Ho VC; Griffiths CE; Ellis CN; Gupta AK; McCuaig CC; Nickoloff BJ; Cooper KD; Hamilton TA; Voorhees JJ
    J Am Acad Dermatol; 1990 Jan; 22(1):94-100. PubMed ID: 2298969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin in psoriasis: pathophysiology and experimental data.
    Mozzanica N; Pigatto PD; Finzi AF
    Dermatology; 1993; 187 Suppl 1():3-7. PubMed ID: 8103687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A.
    Gupta AK; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
    Arch Dermatol Res; 1989; 281(4):219-26. PubMed ID: 2673064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of cyclosporine A on Langerhans cells and regulatory T-cell populations in severe psoriasis: an immunohistochemical and flow cytometric analysis.
    Horrocks C; Duncan JI; Sewell HF; Ormerod AD; Thomson AW
    J Autoimmun; 1990 Oct; 3(5):559-70. PubMed ID: 2252524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine A in psoriasis: an immunohistological study.
    Mozzanica N; Cattaneo A; Pigatto PD; Finzi AF
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):78-84. PubMed ID: 3260053
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of cyclosporine on immunologic mechanisms in psoriasis.
    Cooper KD; Voorhees JJ; Fisher GJ; Chan LS; Gupta AK; Baadsgaard O
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1318-26; discussion 1326-8. PubMed ID: 2277141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis.
    Baker BS; Griffiths CE; Lambert S; Powles AV; Leonard JN; Valdimarsson H; Fry L
    Br J Dermatol; 1987 Apr; 116(4):503-10. PubMed ID: 3495286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of cyclosporine A on T lymphocyte and dendritic cell subpopulations in psoriasis.
    Baker BS; Griffiths CE; Lambert S; Powles AV; Leonard JN; Valdimarsson H; Fry L
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):72-7. PubMed ID: 3260052
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine A inhibits polymorphonuclear leukocyte chemotaxis in vivo.
    Pigatto PD; Mozzanica N; Polenghi MM; Altomare GF; Finzi AF
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):91-4. PubMed ID: 3381307
    [No Abstract]   [Full Text] [Related]  

  • 11. Intralesional cyclosporin in psoriasis: effects on T lymphocyte and dendritic cell subpopulations.
    Baker BS; Powles AV; Savage CR; McFadden JP; Valdimarsson H; Fry L
    Br J Dermatol; 1989 Feb; 120(2):207-13. PubMed ID: 2784322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid occurrence of nodular cutaneous T-lymphocyte infiltrates with cyclosporine therapy.
    Brown MD; Ellis CN; Billings J; Cooper KD; Baadsgaard O; Headington JT; Voorhees JJ
    Arch Dermatol; 1988 Jul; 124(7):1097-100. PubMed ID: 3260470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A: preliminary results in the treatment of psoriasis.
    Bonifati C; Clerico R; Potenza CM; Carlesimo M
    Acta Derm Venereol Suppl (Stockh); 1989; 146():151-4. PubMed ID: 2532844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of resistant severe psoriasis with systemic cyclosporine.
    Picascia DD; Garden JM; Freinkel RK; Roenigk HH
    J Am Acad Dermatol; 1987 Sep; 17(3):408-14. PubMed ID: 3655020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine improves psoriasis in a double-blind study.
    Ellis CN; Gorsulowsky DC; Hamilton TA; Billings JK; Brown MD; Headington JT; Cooper KD; Baadsgaard O; Duell EA; Annesley TM
    JAMA; 1986 Dec; 256(22):3110-6. PubMed ID: 3023712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study.
    Gottlieb SL; Heftler NS; Gilleaudeau P; Johnson R; Vallat VP; Wolfe J; Gottlieb AB; Krueger JG
    J Am Acad Dermatol; 1995 Oct; 33(4):637-45. PubMed ID: 7545705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid response of von Zumbusch psoriasis to cyclosporine.
    Fradin MS; Ellis CN; Voorhees JJ
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):925-6. PubMed ID: 2254478
    [No Abstract]   [Full Text] [Related]  

  • 18. Short-term use of cyclosporin A in severe psoriasis.
    Van Joost T; Heule F; Stolz E; Beukers R
    Br J Dermatol; 1986 May; 114(5):615-20. PubMed ID: 3718852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose cyclosporine A in severe psoriasis.
    Marks J
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):68-71. PubMed ID: 3381305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial.
    Ellis CN; Fradin MS; Messana JM; Brown MD; Siegel MT; Hartley AH; Rocher LL; Wheeler S; Hamilton TA; Parish TG
    N Engl J Med; 1991 Jan; 324(5):277-84. PubMed ID: 1986287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.